Mason’s Story: How 340B Helped a Young Boy Thrive
August 28, 2025
Categories: Patient story
When Mason Helmerichs was just 18 months old, his family’s world changed. He was diagnosed with Eosinophilic Esophagitis (EOE), a chronic condition that causes inflammation in the esophagus. For Mason, this meant food getting stuck, vomiting, and poor weight gain. Food allergies cause this. His parents worked tirelessly to discover which foods triggered his condition, but the process was long and difficult—each answer only came through food trials and biopsies...
The 340 B Drug Program Improves Access to Mental Health Resources
April 18, 2025
Categories: News
As past and current Community Health Needs Assessments have prioritized the growing need for additional mental health services, CHCS continues to seek ways to expand that service offering. Since mid-2023 we have added two full-time mental health providers and now offer extended services in Onaga, Holton and St. Marys.
We understand the importance of access to these and other services in our home communities. The 340B program has helped CHCS provide high quality care to our patients...
340B Drug Pricing Program jeopardized by Big Pharma
October 21, 2020
Categories: News
Section 340B of the Public Health Service Act, also known as the 340B Drug Pricing Program, has provided financial help to hospitals that serve the most vulnerable for more than 25 years. The program requires pharmaceutical manufacturers that participate in Medicaid to sell prescription medications at discounted prices to healthcare organizations like Community HealthCare System, or CHCS, that care for many uninsured and low-income patients. The program helps CHCS decrease prices of prescriptions...
